Rutgers experts are providing sound science and evidence-based recommendations on how to be more resilient to climate change-related impacts. Read how action driven by science could future-proof the Garden State against sea-level rise.
A Culture of Inquiry
Discoveries Around Every Corner
Breakthroughs in knowledge—technology, the humanities, or health care—are the essence of a top research university. At Rutgers, we have a strong track record of discovery—from finding a cure for tuberculosis to developing eco-friendly building materials, just to name a few.
America's Research Engine
Rutgers, The State University of New Jersey stands among America’s highest-ranked public research universities as a member of the Big Ten Academic Alliance and the Association of American Universities. The oldest, largest, and top-ranked public university in the New York/New Jersey metropolitan area, we're a research powerhouse unrivaled in New Jersey with research expenditures topping $730 million annually.
Our Global Reach
At Rutgers, we have a strong track record of discovery with a global footprint—from finding a cure for tuberculosis to developing eco-friendly building materials, and much more.
Responsible Research
As a public research university, we are committed to ensuring the public's trust in our scientific and scholarly endeavors and strive to foster a culture of responsible conduct of research.
Research by the Numbers
$750.8 Million
Research grants and sponsored programs
Fiscal Year 2019
147
Global Patents
Fiscal Year 2019
$736.8 Million
Spent on research and development
Fiscal Year 2018
From Inspiration to Impact
Rutgers researchers are leading the charge forward—asking the big questions, challenging what we know, and sparking innovation—to improve the human condition and to transform the world.
Rutgers is a gold mine of great ideas. Explore some of the many opportunities Rutgers provides for students, faculty, and staff to take great ideas to the next level.
The Food and Drug Administration (FDA) has granted emergency use authorization (EUA) to Rutgers’ RUCDR Infinite Biologics and its collaborators for a new collection approach that utilizes saliva as the primary test biomaterial for the SARS-CoV-2 coronavirus, the first such approval granted by the federal agency.